Could a single dose ease rigid behaviors in autism? new study tests pimavanserin.
NCT ID NCT05999240
First seen Nov 05, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study tests whether pimavanserin can help reduce rigid, repetitive behaviors in people with autism aged 12 to 40. Participants first receive a single dose of the drug or placebo, then all can take the drug openly for 6 weeks. The goal is to see if it is safe and improves behavior flexibility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Autism and the Developing Brain
RECRUITINGWhite Plains, New York, 10605, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Kansas, Center for Research
RECRUITINGLawrence, Kansas, 66045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.